Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Frontiers in Oncology|November 27, 2014
SBRT for the Primary Treatment of Localized Prostate Cancer: The Effect of Gleason Score, Dose and Heterogeneity of Intermediate Risk on Outcome Utilizing 2.2014 NCCN Risk Stratification GuidelinesMatthew Bernetich, Caspian Oliai, Rachelle Lanciano, et al.Leukemia & Lymphoma|December 17, 2024
CPX-351 plus gemtuzumab ozogamicin for relapsed/refractory acute myelogenous leukemia: a University of California Hematologic Malignancies Consortium trialCaspian Oliai, Sunmin Park, Lloyd E Damon, et al.Clinical Lymphoma, Myeloma & Leukemia|July 20, 2022
R-CHOP Vs DA-EPOCH-R for Double-Expressor Lymphoma: A University of California Hematologic Malignancies Consortium Retrospective AnalysisTamer Othman, Juan Penaloza, Shiliang Zhang, et al.Microorganisms|August 26, 2023
Transient SARS-CoV-2 RNA-Dependent RNA Polymerase Mutations after Remdesivir Treatment for Chronic COVID-19 in Two Transplant Recipients: Case Report and Intra-Host Viral Genomic InvestigationShangxin Yang, Ashrit Multani, Jacob M Garrigues, et al.Nature Communications|February 1, 2025
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignanciesYan-Ruide Li, Ying Fang, Siyue Niu, et al.Leukemia & Lymphoma|October 6, 2023
Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemiaDaria Gaut, Caspian Oliai, Jonathan Boiarsky, et al.Transplantation and Cellular Therapy|April 29, 2023
Patient Characteristics and Outcomes of Outpatient Tisagenlecleucel Recipients for B Cell Non-Hodgkin LymphomaNausheen Ahmed, William Wesson, Muhammad Umair Mushtaq, et al.Blood|December 12, 2025
Orca-T versus allogeneic hematopoietic stem cell transplantation (PRECISION-T): a multicenter, randomized phase 3 trialEverett Meyer, Amandeep Salhotra, Arpita Gandhi, et al.Cancer Discovery|November 23, 2022
CD19/CD20 Bispecific Chimeric Antigen Receptor (CAR) in Naive/Memory T Cells for the Treatment of Relapsed or Refractory Non-Hodgkin LymphomaSarah M Larson, Christopher M Walthers, Brenda Ji, et al.Journal of the National Comprehensive Cancer Network : JNCCN|February 15, 2023
NCCN Guidelines® Insights: Hematopoietic Cell Transplantation, Version 3.2022Ayman Saad, Alison Loren, Javier Bolaños-Meade, et al.Pageof 3